Cybersecurity and Regulatory Issues for Drugs and Medical Devices
Pharmaceutical and medical device manufacturers encounter constant threats and challenges. One serious threat is a breach of cybersecurity during the product life cycle and/or during postmarket management. Other challenges to industry include patient-focused drug development, labeling of biosimilars, and regulations for medical device software, among others. The FDA recently issued guidance on Postmarket Management of Cybersecurity in Medical Devices.
The FDA is also considering guidance on other key regulatory drug and device issues. Register now for this informative webinar to learn from two top FDA regulatory lawyers who will assist you in better understanding these critical issues.
DRI is the leading organization of defense attorneys and in-house counsel. Membership in DRI provides access to resources and tools for attorneys who strive to provide high-quality, balanced and excellent service to their clients and corporations. DRI is host to 29 substantive committees whose focus is to develop ongoing and critical dialogue about areas of practice. DRI provides access to resources and tools to grow your practice – members can search a database of more than 65,000 experts, attend renowned CLE seminars, conferences and webcasts, network with 22,000+ like-minded defense practitioners and more.